Following just one incomplete trial involving about 800 participants that was never peer reviewed or published in a medical journal, the U.K. government decided that Moderna's new "Bivalent Spikevax" injection is perfectly safe and effective as a "vaccine candidate" for the so-called Omicron, or Moronic in anagram, variant (BA.1) of the Fauci Flu.
Even though Moderna is known to have fudged past studies and likely engaged in illegal activity, the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) jumped at the opportunity to approve a new covid injection for fast profits and more injuries and deaths. (Related: Earlier this year, thousands of Moderna jabs were recalled following the discovery of a "foreign body" inside the vials.)
What we know so far about National Resilience is that it was founded in November 2020 for the purpose of "reinvent[ing] biomanufacturing" and "democratis[ing] access to medicines" – mainly experimental gene therapies like the original Chinese Virus shots.
Calling its technologies the "medicines of tomorrow," National Resilience is committed to "actively invest in developing powerful new technologies to manufacture complex medicines that are defining the future of therapeutics, including cell and gene therapies, viral vectors, vaccines, and proteins," according to the company.
National Resilience just happened to appear out of nowhere, the same year as the plandemic, with a mission of building "a better system for manufacturing complex medicines to fight deadly diseases," including those that could become the next plandemic.
In April 2021, National Resilience acquired Ology Bioservices Inc., a company that was awarded a $37 million contract from the U.S. military right at the same time when National Resilience was founded.
That money, we are told, was used to develop an advanced anti-covid monoclonal antibody drug. Through the sale, National Resilience also gained access to its first Biosafety Level 3 (BSL-3) laboratory to manufacture its cell and gene therapies, as well as live viral vaccines and vectors and oncolytic viruses.
Last year, National Resilience also forged a partnership with the Canadian government, which plans to invest nearly $155 million into the company's Ontario-based subsidiary, Resilience Biotechnologies Inc.
At the time when this agreement was made, Canadian Minister of Innovation, Science and Industry François-Philippe Champagne admitted that the goal was to "build future pandemic preparedness" and "grow Canada's life science ecosystem as an engine for our economic recovery."
In other words, the powers that be are already working on unleashing the next plandemic and National Resilience, the Canadian government, the U.S. military, and perhaps other establishment candidates are all clamoring for their piece of the pie.
National Resilience CEO Rahul Singhvi used to be the CEO of Novavax, an operating partner at Flagship Pioneering, which played a critical role in Moderna's rise to power as a key plandemic player.
One of National Resilience's board members is former Food and Drug Administration (FDA) commissioner and Pfizer board member Scott Gottlieb, who says he wants National Resilience to become the Amazon Web Services of the biotechnology industry.
It cannot be emphasized enough that National Resilience's mission is to create "futuristic" medicines. It is tied to the DARPA-equivalent of the Wellcome Trust, which is also focused on futuristic, transhumanist "medicines."
What this suggests is that the latest iterations of Fauci Flu shots are, in fact, part of the transhumanist agenda to erase natural human DNA and replace it with ... well, the world is about to find out.
To keep up with the latest news about Fauci Flu shots, be sure to check out Vaccines.news.
Sources for this article include: